What is the primary reason for this 8-K filing?

This 8-K filing is primarily to report UnitedHealth Group's fourth quarter and full-year 2006 financial results. It also serves to inform investors about significant ongoing issues, particularly the restatement of historical financial statements due to past stock option practices.

What is the 'Part D Normalized' financial measure?

'Part D Normalized' results are a non-GAAP measure used by UNH to present its financial performance, specifically adjusting for the timing of recognizing Medicare Part D benefit costs. It assumes full-year Medicare Part D benefit costs are recognized based on actuarially projected utilization over the contract year, enhancing comparability with prior periods.

What are the implications of the stock option accounting issues for investors?

The stock option accounting issues have led to a restatement of financial statements from 1994-2006, meaning historical results are no longer reliable. This has resulted in delayed SEC filings, ongoing investigations by the SEC and other regulatory bodies, potential litigation, and credit rating reviews. These factors introduce uncertainty regarding future financial reporting, outlook, and overall business stability.

What are the main risks UNH is facing according to this filing?

UNH is facing several key risks, including the potential for adverse outcomes from regulatory investigations and litigation related to stock options, further credit rating downgrades, difficulties in maintaining access to liquidity due to potential covenant violations and delayed filings, and the ongoing challenge of managing healthcare costs in a competitive and regulated industry.

UNH 8-K: Earnings & Results

Summary

UnitedHealth Group (UNH) filed an 8-K on January 18, 2007, to report its fourth quarter and full-year 2006 financial results. The report highlights the company's performance alongside significant disclosures regarding historical stock option practices. The company is undergoing a restatement of financial statements from 1994 to 2006 due to these practices, which may impact future outlook and has led to delays in SEC filings. Key financial figures are presented, including both GAAP and non-GAAP measures, such as 'Part D Normalized' results to aid comparability. Investors should note the ongoing investigations, potential litigation, and credit rating reviews stemming from the stock option issue. The company emphasizes its efforts to remediate internal control weaknesses and manage healthcare costs, while also outlining competitive pressures and regulatory risks inherent in the healthcare industry.

Key Highlights

1UNH announced Q4 and full-year 2006 financial results, with full financial details available in an accompanying press release (Exhibit 99.1).
2The company is undergoing a restatement of historical financial statements from 1994-2006 due to improper stock option grant accounting, with a formal SEC investigation ongoing.
3Delays in filing quarterly reports (10-Q) due to the restatement process may adversely affect UNH's ability to raise capital and access liquidity.
4The company is using non-GAAP financial measures, such as 'Part D Normalized' results, to provide a clearer picture of its operations, particularly regarding Medicare Part D benefit costs.
5UNH disclosed significant risks and uncertainties, including ongoing regulatory inquiries, litigation related to stock option practices, potential credit rating downgrades, and credit facility covenant issues.
6Efforts are underway to remediate a material weakness in internal controls related to stock option administration and accounting.
7The company highlighted the importance of managing healthcare costs, competitive landscape, its AARP relationship, and uncertainties surrounding Medicare program changes.

UNITEDHEALTH GROUP INC 8-K Report, Financial Results (Jan 18, 2007)

Summary

Key Highlights

Frequently Asked Questions